Serum Institute of India Seeks Emergency Use Authorisation from India's Drug Regulator for ... - Latest Tweet by PTI News
The latest Tweet by PTI News states, 'Serum Institute of India seeks emergency use authorisation from India's drug regulator for its COVID-19 vaccine Covovax for 12 to 17 year age group'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)